Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer’s disease
Congratulations to: Samir Yahiaouia, Katia Hamidoucheb, Céline Ballandonnea, Audrey Davisa, Jana Sopkova de … En savoir plus